Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 25, 2026 11:11 ET | Source: Faruqi & Faruqi LLP

NKTR INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or...
March 25, 2026 10:00 ET | Source: Eascra Biotech

Eascra Biotech Takes First Place at TechConnect Bio in Space Innovation Challenge

Eascra Biotech, a nanomedicine startup, has won first place at the TechConnect Bio in Space Innovation Challenge
March 09, 2026 04:00 ET | Source: JA Worldwide, Inc.

Students from JA Ecuador Win 2026 De La Vega Global Entrepreneurship Award

BOSTON, March 09, 2026 (GLOBE NEWSWIRE) -- Founded in 2021 by tech-legend Ralph de la Vega, former President and CEO of AT&T Mobile and Business Solutions, the De La Vega Global Entrepreneurship...
March 06, 2026 17:01 ET | Source: Faruqi & Faruqi LLP

NKTR SHAREHOLDER NOTICE: Faruqi & Faruqi, LLP Reminds Nektar Therapeutics (NKTR) Investors of Securities Class Action Deadline on May 5, 2026

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Nektar To Contact Him Directly To Discuss Their Options If you purchased or...
February 24, 2026 09:00 ET | Source: Human Continuum Inc.

Human Continuum Appoints Dr. Michael Milligan, MD, MBA, as its Chief Medical Officer to Oversee Innovative Applications for Next-Generation Extracellular Vesicle Therapeutics

New York, N.Y., Feb. 24, 2026 (GLOBE NEWSWIRE) -- Human Continuum Inc. (“HC” or “the Company”), a developer of platelet-derived and plant-based exosome therapeutics and diagnostics, today announced...
February 19, 2026 03:30 ET | Source: Custom Market Insights

Global Amyotrophic Lateral Sclerosis Therapeutics Market Size/Share Worth USD 1964 Million by 2035 at 11.5% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth Rate, Value, SWOT Analysis)

Global ALS therapeutics market is expected to grow from USD 1.05B in 2025 to USD 1.96B by 2034 at 11.5% CAGR, driven by new therapies and rising worldwide.
February 17, 2026 14:22 ET | Source: Network for Teaching Entrepreneurship (NFTE)

NFTE Launches Reimagined Global Youth Entrepreneurship Showcase

New York, NY, Feb. 17, 2026 (GLOBE NEWSWIRE) -- The Network for Teaching Entrepreneurship (NFTE) today announced the rebranding and expansion of its flagship challenge series into the NFTE Youth...
February 16, 2026 10:00 ET | Source: MarketsandMarkets Research Pvt. Ltd.

Global Oligonucleotide Therapeutics Market Set to Surge to USD 17.70 Billion by 2030 | MarketsandMarkets™

Delray Beach, FL, Feb. 16, 2026 (GLOBE NEWSWIRE) -- Strategic investments in ASO and siRNA platforms, coupled with breakthrough delivery technologies, position oligonucleotide therapeutics as...
February 10, 2026 07:50 ET | Source: SAMFINE CREATION HOLDINGS GROUP LIMITED

Samfine Creation Holdings Group Limited: Exploring “Printing + IP + Ecosystem” as a Strategic Direction for Chinese Cultural Creative Products

Samfine (SFHG) evolves Hong Kong printing into "Printing+IP," partnering with artist Jin Cheng to export Chinese animation lifestyle products globally.
February 04, 2026 13:44 ET | Source: Azzet

Azzet, Inc. Expands Board of Directors With Appointment of Accomplished CEO and Governance Director Yvonne Howie

Azzet appoints governance leader Yvonne Howie to its Board, strengthening leadership as the global investment marketplace accelerates international growth.